P
Patil Armenian
Researcher at University of California, San Francisco
Publications - 30
Citations - 1418
Patil Armenian is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Poison control & Fentanyl. The author has an hindex of 13, co-authored 29 publications receiving 1154 citations.
Papers
More filters
Journal ArticleDOI
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
TL;DR: In 2014, the first illicit pills containing fentanyl, fentanyl analogs, and other novel synthetic opioids such as U-47700 were detected as mentioned in this paper, and since then, fentanyl has caused deaths in every state and fentanyl and its analogs have completely infiltrated the North American heroin supply.
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review - eScholarship
TL;DR: Synthetic opioids are an increasingly major public health threat requiring vigilance from multiple fields including law enforcement, government agencies, clinical chemists, pharmacists, and physicians, to name a few, in order to stem its tide.
Journal ArticleDOI
Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
TL;DR: LC-HR/MS is more suitable to clinical toxicology because the drugs present in a sample are rarely known a priori, and tentative identifications of unknowns can be made without the availability of a reference standard or a library spectrum.
Journal ArticleDOI
Fentanyl and a Novel Synthetic Opioid U-47700 Masquerading as Street “Norco” in Central California: A Case Report
TL;DR: Street Norco purchased in Central California resulted in altered mental status requiring naloxone reversal because of fentanyl and the novel synthetic opioid U-47700, a nonfentanyl-based synthetic opioid with 7.5 times the binding affinity of morphine to μ-opioid.
Journal ArticleDOI
Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose
Deborah L. French,Patil Armenian,Weiming Ruan,Alicia Wong,Kenneth Drasner,Kent R. Olson,Alan H.B. Wu +6 more
TL;DR: It was found that administration of Intralipid® was followed by a decrease in verapamil concentration once the lipid had been removed from the sample, demonstrating that Intralipsid was effective in sequestering verAPamil, effectively removing it from the serum, and supporting its use in the treatment of verap amil overdose.